The global aesthetic medicine market size is expected to reach around US$ 155.67 billion by 2030 and is expected to grow at an impressive double-digit rate of 9.5% from 2022 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global aesthetic medicine market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
- The global aesthetic medicine market value is expected to reach US$142.2 billion by 2030
- The non-invasive procedures segment captured a market share of around 51% in 2020
- Around 4.4 million Botox injection procedures were performed in 2020 in US
- India is among the top five non-surgical procedures performing nations at global level
- Global geriatric population is expected to reach 1.5 billion by 2050
- North America accounted for a revenue of around US$20.66 billion in 2020
- Asia Pacific aesthetic medicine market is projected to grow at a CAGR of 10.7% from 2021 to 2030
- Botox injection procedures increased by 845% from 2000 to 2018, in US
Report Scope of the Aesthetic Medicine Market
| Report Coverage | Details |
| Market Size by 2030 | USD 155.67 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 9.5% |
| North America Market Share in 2021 | 36% |
| Non-invasive Procedures Segment Market Share in 2021 | 51% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
What are the key trends in the Global Aesthetic Medicine Market?
The growing urge among the people to look young and fit is fueling the demand for aesthetic medicine in developed and developing economies. The rapidly surging popularity of non-invasive and minimally invasive surgical procedures is driving the growth of the aesthetic medicine market across the globe. The demand for the cosmetics surgery is boosting the growth of the aesthetic medicine market. The rising adoption of advanced laser resurfacing technology and aesthetic injectable is propelling the growth of the aesthetic medicines globally. Furthermore, the economic benefits and conveniences associated with the minimally invasive procedures like less pain and quick recovery is fostering its demand among the consumers.
What are the key challenges in the Global Aesthetic Medicine Market?
There is a risk of potential side effects associated with the aesthetic procedures. There are certain complications and risks that the consumers may face during or after the procedure. The associated risks are the major factor that may restrict the consumers to adopt the aesthetic treatments. Furthermore, the high costs involved with the treatment and the low awareness in the developing and underdeveloped economies may hamper the market growth during the forecast period. Furthermore, the manufacturers faces a complicated regulations pertaining to the commercialization of various aesthetic medicines.
Asia Pacific is expected to grow at the highest CAGR of 10.7% during the forecast period
The emerging economies like China, India, and South Korea are the growth drivers of the Asia Pacific aesthetic medicine market. South Korea has become a hub for aesthetic treatments owing to the presence of advanced treatment facilities and skilled cosmetics surgeons. The rising awareness among the population regarding the availability of various invasive and non-invasive procedures to improve the aesthetic appearances and anti-aging injectable is boosting the growth of the market. The rapidly growing geriatric population in the region is projected to increase the demand for the aesthetic medicines in the forthcoming years.
According to the United Nations, the low and middle income countries are expected to be the home of around 80% of the global geriatric population by 2050. Furthermore, around 93% of the road traffic accidents occur in low and middle income nations, which also contribute towards the increasing demand for the aesthetic medicine market in Asia Pacific. The rising technological advancements and rising penetration of the aesthetic treatment products in the region coupled with rising personal disposable income is augmenting the growth of the aesthetic medicine market in Asia Pacific.
Approximately 36% of the Global Aesthetic Medicine Market Captured by North America
The rapidly shifting consumers’ attitude towards beauty, wellness, and aging has surged the awareness and acceptance of aesthetic medicines and procedures, which has resulted in an increasing demand for the aesthetic medicines among the men. US is the largest market in North America. The presence of aesthetic treatment services via beauty bars, med spas, and aesthetic clinics in the region has significantly fostered the growth of the aesthetic medicine market.
The rapidly aging population in US is expected to be a prominent growth driver of the market in the upcoming future. It is estimated that around 24% of the total population in US will constitute the elderly population by 2060. The rising concerns among the middle and high income groups regarding their physical appearance are expected to boost the demand for the aesthetic medicine in US. Botox injection is the leading procedure and the most demanded procedure in North America. According to the American Society of Plastic Surgeons Botox injections procedures has increased by around 845% between 2000 and 2018.
Our Free Sample Reports Includes:
- In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
- Impact Analysis 150+ Pages Research Report (Including latest research).
- Provide chapter-wise guidance on request 2022 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
- Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Precedence Research methodology.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1667
Research Methodology
A unique research methodology has been utilized to conduct comprehensive research on the growth of the global aesthetic medicine market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the draw conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global aesthetic medicine market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.
Why should you invest in this report?
If you are aiming to enter the global aesthetic medicine market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for aesthetic medicine are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global aesthetic medicine market include:
- AbbVie Inc.
- Galderma
- Alma Lasers
- Cynosure
- Johnson & Johnson Private Limited
- Lumenis Be Ltd.
- Solta Medical
- Candela Medical
- Hologic, Inc.
- Dentsply Sirona
Market Segmentation:
By Procedure Type
- Non-Invasive Procedure
- Botox Injections
- Microdermabrasion
- Soft Tissue Fillers
- Laser Hair Removal
- Chemical Peel
- Others
- Invasive Procedure
- Liposuction
- Nose Reshaping
- Breast Augmentation
- Tummy Tuck
- Eyelid Surgery
- Others
By Product Type
- Energy-Based Devices
- Laser-based Aesthetic Device
- Radiofrequency (RF)-based Aesthetic Device
- Light-based Aesthetic Device
- Ultrasound Aesthetic Device
- Others
- Implants
- Facial Implants
- Breast Implants
- Others
- Anti-Wrinkle Products
- Botulinum Toxin
- Dermal Fillers
- Others
By Application
- Surgical
- Non-Surgical
By End-User
- Medical Spas and Beauty Centres
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Home Use
By Gender
- Males
- 18 years and below
- 19-34 years
- 35-50 years
- 51-64 years
- 65 years and above
- Females
- 18 years and below
- 19-34 years
- 35-50 years
- 51-64 years
- 65 years and above
By Route of Administration
- Oral
- Topical
Regional Analysis:
The geographical analysis of the global aesthetic medicine market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global aesthetic medicine Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global aesthetic medicine market in 2030?
- What is the expected CAGR for the aesthetic medicine market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global aesthetic medicine market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Route of Administration Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Aesthetic Medicine Market
5.1. COVID-19 Landscape: Aesthetic Medicine Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Aesthetic Medicine Market, By Product Type
8.1. Aesthetic Medicine Market, by Product Type, 2022-2030
8.1.1. Energy-Based Devices
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Implants
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Anti-Wrinkle Products
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Dermal Fillers
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Botulinum Toxin
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Aesthetic Medicine Market, By Procedure Type
9.1. Aesthetic Medicine Market, by Procedure Type, 2022-2030
9.1.1. Non-Invasive Procedure
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Invasive Procedure
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Aesthetic Medicine Market, By Application Type
10.1. Aesthetic Medicine Market, by Application Type, 2022-2030
10.1.1. Surgical
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Non-Surgical
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Aesthetic Medicine Market, By End-User Type
11.1. Aesthetic Medicine Market, by End-User Type, 2022-2030
11.1.1. Medical Spas and Beauty Centres
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Hospitals and Clinics
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Ambulatory Surgical Centers
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Aesthetic Medicine Market, By Gender
12.1. Aesthetic Medicine Market, by Gender, 2022-2030
12.1.1. Males
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Females
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Aesthetic Medicine Market, By Route of Administration
13.1. Aesthetic Medicine Market, by Procedure Type, 2022-2030
13.1.1. Oral
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Topical
13.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Aesthetic Medicine Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.1.3. Market Revenue and Forecast, by Application (2017-2030)
14.1.4. Market Revenue and Forecast, by End-User (2017-2030)
14.1.5. Market Revenue and Forecast, by Gender (2017-2030)
14.1.6. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.7.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.1.7.3. Market Revenue and Forecast, by Application (2017-2030)
14.1.7.4. Market Revenue and Forecast, by End-User (2017-2030)
14.1.8. Market Revenue and Forecast, by Gender (2017-2030)
14.1.8.1. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.9.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Application (2017-2030)
14.1.9.4. Market Revenue and Forecast, by End-User (2017-2030)
14.1.10. Market Revenue and Forecast, by Gender (2017-2030)
14.1.11. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.2.3. Market Revenue and Forecast, by Application (2017-2030)
14.2.4. Market Revenue and Forecast, by End-User (2017-2030)
14.2.5. Market Revenue and Forecast, by Gender (2017-2030)
14.2.6. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.8.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
14.2.9. Market Revenue and Forecast, by End-User (2017-2030)
14.2.10. Market Revenue and Forecast, by Gender (2017-2030)
14.2.10.1. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.11.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Application (2017-2030)
14.2.12. Market Revenue and Forecast, by End-User (2017-2030)
14.2.13. Market Revenue and Forecast, by Gender (2017-2030)
14.2.14. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.15.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.2.15.3. Market Revenue and Forecast, by Application (2017-2030)
14.2.15.4. Market Revenue and Forecast, by End-User (2017-2030)
14.2.16. Market Revenue and Forecast, by Gender (2017-2030)
14.2.16.1. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.17.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.2.17.3. Market Revenue and Forecast, by Application (2017-2030)
14.2.17.4. Market Revenue and Forecast, by End-User (2017-2030)
14.2.18. Market Revenue and Forecast, by Gender (2017-2030)
14.2.18.1. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.3.3. Market Revenue and Forecast, by Application (2017-2030)
14.3.4. Market Revenue and Forecast, by End-User (2017-2030)
14.3.5. Market Revenue and Forecast, by Gender (2017-2030)
14.3.6. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.7.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
14.3.7.4. Market Revenue and Forecast, by End-User (2017-2030)
14.3.8. Market Revenue and Forecast, by Gender (2017-2030)
14.3.9. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.10.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Application (2017-2030)
14.3.10.4. Market Revenue and Forecast, by End-User (2017-2030)
14.3.11. Market Revenue and Forecast, by Gender (2017-2030)
14.3.11.1. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.12.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.3.12.3. Market Revenue and Forecast, by Application (2017-2030)
14.3.12.4. Market Revenue and Forecast, by End-User (2017-2030)
14.3.12.5. Market Revenue and Forecast, by Gender (2017-2030)
14.3.12.6. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.13.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.3.13.3. Market Revenue and Forecast, by Application (2017-2030)
14.3.13.4. Market Revenue and Forecast, by End-User (2017-2030)
14.3.13.5. Market Revenue and Forecast, by Gender (2017-2030)
14.3.13.6. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.4.3. Market Revenue and Forecast, by Application (2017-2030)
14.4.4. Market Revenue and Forecast, by End-User (2017-2030)
14.4.5. Market Revenue and Forecast, by Gender (2017-2030)
14.4.6. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.7.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
14.4.7.4. Market Revenue and Forecast, by End-User (2017-2030)
14.4.8. Market Revenue and Forecast, by Gender (2017-2030)
14.4.9. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.10.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Application (2017-2030)
14.4.10.4. Market Revenue and Forecast, by End-User (2017-2030)
14.4.11. Market Revenue and Forecast, by Gender (2017-2030)
14.4.12. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.13.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.4.13.3. Market Revenue and Forecast, by Application (2017-2030)
14.4.13.4. Market Revenue and Forecast, by End-User (2017-2030)
14.4.13.5. Market Revenue and Forecast, by Gender (2017-2030)
14.4.13.6. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.14.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.4.14.3. Market Revenue and Forecast, by Application (2017-2030)
14.4.14.4. Market Revenue and Forecast, by End-User (2017-2030)
14.4.14.5. Market Revenue and Forecast, by Gender (2017-2030)
14.4.14.6. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.5.3. Market Revenue and Forecast, by Application (2017-2030)
14.5.4. Market Revenue and Forecast, by End-User (2017-2030)
14.5.5. Market Revenue and Forecast, by Gender (2017-2030)
14.5.6. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.7.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.5.7.3. Market Revenue and Forecast, by Application (2017-2030)
14.5.7.4. Market Revenue and Forecast, by End-User (2017-2030)
14.5.8. Market Revenue and Forecast, by Gender (2017-2030)
14.5.8.1. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.9.2. Market Revenue and Forecast, by Procedure (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Application (2017-2030)
14.5.9.4. Market Revenue and Forecast, by End-User (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Gender (2017-2030)
14.5.9.6. Market Revenue and Forecast, by Route of Administration (2017-2030)
Chapter 15. Company Profiles
15.1. AbbVie Inc.
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Galderma
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Alma Lasers
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Cynosure
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Johnson & Johnson Private Limited
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Lumenis Be Ltd.
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Solta Medical
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Candela Medical
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Hologic, Inc.
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Dentsply Sirona
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments